M. Obermeier 4/2010 Update 2010 and outlook
Basis of the HIV-GRADE internet-tool HIV-Alg module from Stanford-HIVdb PERL-source-code is freely available Software is in development since 1999 Algorithm Specification Interface (ASI) M. Obermeier 4/2010
Algorithm Specification Interface (ASI) Rule-based algorithms can be described using xml-syntax Xml-Files available for Stanford- HIVdb, ANRS and REGA HIV-GRADE can be described in a compatible format. M. Obermeier 4/2010
Workflow sequences mutation-lists identify genes alignment on Consensus send sequences B Sequence to geno2pheno extraction of mutations rule-based analysis geno2pheno report detailled output batch output M. Obermeier 4/2010
Sequences analysed with HIV-GRADE 2000 1800 Number of Sequences 1600 1400 1200 1000 800 600 400 200 0 Apr Mai Jun Jul Aug Sep Okt Nov Dez Jan Feb Mrz 09 09 09 09 09 09 09 09 09 10 10 10 Month M. Obermeier 4/2010
M. Obermeier 4/2010 Data traffic by countries
Active drug score (ADS) transformation of a qualitative statement into a quantitative factor Resistant => 0 Intermediate => 0.33 limited susceptibility => 0.66 Susceptible => 1 Hypersusceptible => 1.33 Sum of all given drugs M. Obermeier 4/2010
M. Obermeier 4/2010 Combination analysis
M. Obermeier 4/2010 HIV-2 tool
M. Obermeier 4/2010 HIV-2 tool
HBV-tool Program code clean-up Direct link to geno2pheno- HBV M. Obermeier 4/2010
Outlook HIV-GRADE HCV tool HIV-GRADE V3 tool Mutation analyses and simple entry of V3-loop sequences into tropism classification tools More combination analysis M. Obermeier 4/2010
HIV-GRADE association Thomas Berg, Medizinisches Labor Dr. Berg, Berlin Patrick Braun, PZB, Aachen Martin Däumer, Labor Dr. Thiele Kaiserslautern Josef Eberle, Pettenkofer-Institut, München Robert Ehret, PZB, Aachen Rolf Kaiser, Institut für Virologie, Köln Klaus Korn, NRZ für Retroviren, Erlangen Claudia Kücherer, RKI, Berlin Harm Müller, Labor Dr.Fenner, Hamburg Christian Noah, Labor Lademannbogen, Hamburg Martin Obermeier, Medizinisches Labor Dr. Berg, Berlin Alexander Thielen, MPI, Saarbrücken Martin Stürmer, Institut für Medizinische Virologie, Frankfurt Hauke Walter, NRZ für Retroviren, Erlangen Eva Wolf, MUC research, Munich
Recommend
More recommend